Journal article · 2019 · Open access

Evaluation of an antibody to α 4 β 7 in the control of SIVmac239- nef-stop infection

Michele Di Mascio, Jeffrey D. Lifson, Sharat Srinivasula, I. Kim, Paula DeGrange, Brandon F. Keele, Aaron J. Belli, Keith A. Reimann, Y. Wang, Michael A. Proschan, Henry Clifford Lane, Anthony S. Fauci

Science, 365(6457), 1025–1029 · Published 5 September 2019 · DOI 10.1126/science.aav6695

Open full textView at the publisherCite this paper

In brief

“Evaluation of an antibody to α 4 β 7 in the control of SIVmac239- nef-stop infection” is a 2019 journal article by Michele Di Mascio and 11 co-authors, published in Science. OpenAlex counts 38 citations as of 19 November 2026. It is open access: the full text is free to read at Europe PMC (PubMed Central).

Citations
38
Most cited in
2020 (10)
Field-weighted impact
2.57
References
29
Authors
12

Abstract

An antibody is not the antidote An HIV therapeutic that would give long-term remission without sustained antiretroviral therapy (ART) is a long-term goal. Byrareddy et al. [ Science 354 , 197 (2016)] reported that treating simian immunodeficiency virus (SIV)–positive macaques with an antibody against integrin α 4 β 7 during and after ART results in sustained virologic control after stopping all treatment. Three studies in this issue question the reproducibility of that result. Di Mascio et al. sequenced the virus used in the 2016 study and found that it was a variant with a stop codon in the nef gene rather than a wild-type virus. Abbink et al. used the same antibody for α 4 β 7 as before but tested control of a more commonly used pathogenic virus. Iwamato et al. used the same nef -stop virus as in the earlier paper but combined the antibody against the integrin with an antibody against the SIV envelope glycoprotein, which also blocks viral binding of the integrin. None of these three new studies found that treating with the antibody had any effect on virologic control after stopping ART treatment. Science , this issue p. 1025 , p. 1029 , p. 1033

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Di Mascio, M., Lifson, J. D., Srinivasula, S., Kim, I., DeGrange, P., Keele, B. F., Belli, A. J., Reimann, K. A., Wang, Y., Proschan, M. A., Lane, H. C., & Fauci, A. S. (2019). Evaluation of an antibody to α 4 β 7 in the control of SIVmac239- nef-stop infection. Science, 365(6457), 1025–1029. https://doi.org/10.1126/science.aav6695

MLA 9

Di Mascio, Michele, et al. “Evaluation of an antibody to α 4 β 7 in the control of SIVmac239- nef-stop infection.” Science, vol. 365, no. 6457, 2019, pp. 1025–1029. https://doi.org/10.1126/science.aav6695.

Chicago

Di Mascio, Michele, Jeffrey D. Lifson, Sharat Srinivasula, I. Kim, Paula DeGrange, Brandon F. Keele, Aaron J. Belli, et al. 2019. “Evaluation of an antibody to α 4 β 7 in the control of SIVmac239- nef-stop infection.” Science 365 (6457): 1025–1029. https://doi.org/10.1126/science.aav6695.

Harvard

Di Mascio, M. et al. (2019) ‘Evaluation of an antibody to α 4 β 7 in the control of SIVmac239- nef-stop infection’, Science, 365(6457), pp. 1025–1029. doi:10.1126/science.aav6695.

IEEE

M. Di Mascio et al., “Evaluation of an antibody to α 4 β 7 in the control of SIVmac239- nef-stop infection,” Science, vol. 365, no. 6457, pp. 1025–1029, 2019, doi: 10.1126/science.aav6695.

BibTeX

@article{dimascio2019evaluation,
  title     = {{Evaluation of an antibody to α 4 β 7 in the control of SIVmac239- nef-stop infection}},
  author    = {Di Mascio, Michele and Lifson, Jeffrey D. and Srinivasula, Sharat and Kim, I. and DeGrange, Paula and Keele, Brandon F. and Belli, Aaron J. and Reimann, Keith A. and Wang, Y. and Proschan, Michael A. and Lane, Henry Clifford and Fauci, Anthony S.},
  journal   = {Science},
  year      = {2019},
  volume    = {365},
  number    = {6457},
  pages     = {1025--1029},
  doi       = {10.1126/science.aav6695},
  url       = {https://doi.org/10.1126/science.aav6695}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Citations by year

YearCitationsShare of the best year
201611
201944
20201010
202188
202244
202333
202422
202555
202611

Its field-weighted citation impact is 2.57: it has been cited 2.57 times as often as the average work of the same field, type and year (1.00 is the world average).

Topic and keywords

Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment

  • SIVmac239
  • alpha4beta7 integrin
  • antibody therapy
  • antiretroviral therapy withdrawal
  • reproducibility
  • simian immunodeficiency virus
  • macaque

Work with this paper

Most-cited papers in Immunology and Microbiology

All highly cited Immunology and Microbiology papers

Questions about this paper

How do I cite this paper in APA style?

Di Mascio, M., Lifson, J. D., Srinivasula, S., Kim, I., DeGrange, P., Keele, B. F., Belli, A. J., Reimann, K. A., Wang, Y., Proschan, M. A., Lane, H. C., & Fauci, A. S. (2019). Evaluation of an antibody to α 4 β 7 in the control of SIVmac239- nef-stop infection. Science, 365(6457), 1025–1029. https://doi.org/10.1126/science.aav6695

How many times has this paper been cited?

38 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at Europe PMC (PubMed Central): sign in and open the full text from this page.

Who wrote this paper?

Michele Di Mascio, Jeffrey D. Lifson, Sharat Srinivasula, I. Kim, Paula DeGrange, Brandon F. Keele, Aaron J. Belli, Keith A. Reimann, Y. Wang, Michael A. Proschan, Henry Clifford Lane, Anthony S. Fauci.

What is the DOI of this paper?

10.1126/science.aav6695, permanently at https://doi.org/10.1126/science.aav6695. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.